2017. Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s102. DOI:https://doi.org/10.25251/skin.1.supp.101.